Loading...
Please wait, while we are loading the content...
Downregulation of miR‑142‑5p inhibits human aortic smooth muscle cell proliferation and migration by targeting MKL2.
| Content Provider | Europe PMC |
|---|---|
| Author | Wu, Wei Shang, Yuqiang Dai, Shiling Yu, Chunjun Wang, Jie |
| Copyright Year | 2020 |
| Abstract | The increased proliferation and migration of vascular smooth muscle cells (VSMCs) are critical in the progression of atherosclerosis (AS). Platelet-derived growth factor type BB (PDGF-BB) may induce VSMC proliferation and migration. miR-142-5p plays a critical role in various biological processes, including tumorigenesis, angiogenesis and inflammation. However, whether miR-142-5p is involved in regulating the pathological process of arteriosclerosis remains to be elucidated. Therefore, in this study, the role of miR-142-5p in PDGF-BB-induced human aortic smooth muscle cell (HSAMC) proliferation and migration was investigated. The results revealed that the expression level of miR-142-5p was enhanced in the serum of patients with AS, while that of its target gene, myocardin-like protein 2 (MKL2) was decreased, compared with that in healthy volunteers. Moreover, there was a negative correlation between miR-142-5p and MKL2 expression in the serum of patients with AS. Furthermore, the downregulation of miR-142-5p inhibited PDGF-BB-induced HASMC proliferation and migration; however, the inhibition of HASMC proliferation and migration was reversed by co-transfection with small interfering RNA (siRNA) against MKL2 (siRNA-MKL2). In addition, transfection with miR-142-5p inhibitor significantly increased the expression levels of MKL2, and decreased those of matrix metalloproteinase (MMP)2 and 9, and these effects were reversed by transfection with siRNA-MKL2. Finally, MKL2 was proven to be a target of miR-142-5p. On the whole, the findings of the present study demonstrate that the downregulation of miR-142-5p inhibits human aortic smooth muscle cell (HSAMC) proliferation and migration possibly by targeting MKL2. Hence, miR-142-5p may prove to be a novel therapeutic target in the treatment of AS. |
| ISSN | 17912997 |
| Journal | Molecular Medicine Reports |
| PubMed Central reference number | PMC7248461 |
| Issue Number | 1 |
| PubMed reference number | 32626937 |
| e-ISSN | 17913004 |
| DOI | 10.3892/mmr.2020.11093 |
| Language | English |
| Publisher | D.A. Spandidos |
| Publisher Date | 2020-04-24 |
| Access Restriction | Open |
| Rights License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Copyright: © Wu et al. |
| Subject Keyword | microRNA-142-5p myocardin-like protein 2 atherosclerosis proliferation and migration human aortic smooth muscle |
| Content Type | Text |
| Resource Type | Article |
| Subject | Genetics Molecular Biology Biochemistry Cancer Research Molecular Medicine Oncology |